Methylergonovine Maleate Tablet
NDC Package 70010-786-07

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings

Package Information

Methylergonovine Maleate tablets is a medication used after childbirth to help stop bleeding from the uterus. This formulation utilizes a tablet delivery system. Marketed by Granules Pharmaceuticals Inc., this product is identified by NDC 70010-786 and is authorized under FDA application ANDA210424.

Identification & Billing

NDC Package Code
70010-786-07
Package Description
7 TABLET in 1 BOTTLE
Product Code
11-Digit Billing Format
70010078607
RxNorm Crosswalk
RxCUI: 996824 - methylergonovine maleate 0.2 MG Oral Tablet

Clinical Specifications

Proprietary Name
Methylergonovine Maleate
Non-Proprietary Name
Methylergonovine Maleate
Substance Name
Methylergonovine Maleate
Dosage Form
Tablet - A solid dosage form containing medicinal substances with or without suitable diluents.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
Usage Information
This medication is used after childbirth to help stop bleeding from the uterus. Methylergonovine belongs to a class of drugs known as ergot alkaloids. It works by increasing the rate and strength of contractions and the stiffness of the uterus muscles. These effects help to decrease bleeding.

Regulatory & Marketing

Labeler Name
Granules Pharmaceuticals Inc.
Product Type
Human Prescription Drug
FDA Application #
ANDA210424
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
05-25-2018
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (70010-786). Click a package code to view its specific billing and regulatory data.

100 TABLET in 1 BOTTLE
12 TABLET in 1 BOTTLE
28 TABLET in 1 BOTTLE

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 70010-786-07 identifies a specific commercial package of 7 tablet in 1 bottle of Methylergonovine Maleate, a human prescription drug labeled by Granules Pharmaceuticals Inc.. This tablet is formulated for oral use and contains methylergonovine maleate as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Granules Pharmaceuticals Inc. on May 25, 2018. The current certification is valid through December 31, 2026.

What are the primary indications for this medication?

This medication is used after childbirth to help stop bleeding from the uterus. Methylergonovine belongs to a class of drugs known as ergot alkaloids. It works by increasing the rate and strength of contractions and the stiffness of the uterus muscles. These effects help to decrease bleeding.

How is this Granules Pharmaceuticals Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 70010078607. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
70010-786-07
11-Digit CMS (5-4-2)
70010-0786-07

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.